Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Fluorouracil, Hydroxyurea, Cetuximab and Twice-Daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
This study is currently recruiting participants.
Study NCT00462735 Information provided by Mount Sinai School of Medicine
First Received: April 18, 2007 Last Updated: June 17, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Head and Neck Cancer
Cancer of the Pharynx
Cancer of the Larynx
Nose Neoplasms
Paranasal Sinus Neoplasms
Cancer of the Oral Cavity
Additional conditions recognized in this trial
Head and Neck Neoplasms
Laryngeal Neoplasms
Neoplasms
Pharyngeal Neoplasms
More general conditions related to this trial
Bone Diseases
Bone Neoplasms
Laryngeal Diseases
Musculoskeletal Diseases
Neoplasms by Site
Nose Diseases
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Paranasal Sinus Diseases
Pharyngeal Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Skull Neoplasms
Stomatognathic Diseases
Interventions listed in this trial
cetuximab
hydroxyurea
fluorouracil
chemotherapy
radiotherapy
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antisickling Agents
Enzyme Inhibitors
Hematologic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Mount Sinai School of Medicine
Back to top of Main Content
